Depouhon SPRLU SRL

Depouhon SPRLU reported revenue of 99,276 € for the 2025 financial year (annual accounts filed with the NBB on 29 Jul 2026).

Company number (CBE) 0554.918.687 · VAT BE0554918687
1450 Chastre
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 24 Jun 2014 (≈ 12 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Depouhon SPRLU shows with a free account.

See the score
Profile
SRL since 2014
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue99,276 €
Net result55,975 €
Equity34,764 €
Cash350,658 €
EBITDA73,593 €
Total assets374,564 €
The line marks its sector median: 41.5% (1048 companies).

Change 2022 → 2025: Revenue +12 % Equity +50 % Total assets -28 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Depouhon SPRLU's annual accounts

20252024202320222021
Revenue99,276 €
Net result55,975 €
Equity34,764 €
Cash350,658 €
EBITDA73,593 €
Total assets374,564 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 29 Jul 2026
  • Year ended 31 Dec 2024filed on 11 Jul 2025
  • Year ended 31 Dec 2023filed on 05 Jul 2024
  • Year ended 31 Dec 2022filed on 07 Jun 2023
  • Year ended 31 Dec 2021filed on 27 Jul 2022

Depouhon SPRLU's financial analysis

Management and control of Depouhon SPRLU

1 active director(s) in the register.

Depouhon SPRLU's shareholders and holdings →

Depouhon SPRLU's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0554.918.687
VAT number
BE0554918687
Peppol
Registered · 0208:0554918687 · as of 10 Nov 2026
Legal form
SRL
Incorporated
24 Jun 2014
Registered office
1450 Chastre
Latest accounts
2025 · filed on 29 Jul 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Depouhon SPRLU (SRL) has been based in Chastre since 2014, active in: retail sale of pharmaceutical products. For 2025, it reports revenue of 99,276 €, a net profit of 55,975 € and equity of 34,764 €. Its solvency stands at 9.3%, below the median of its sector (41.5%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Depouhon SPRLU

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Depouhon SPRLU

What is the revenue of Depouhon SPRLU?

According to the 2025 annual accounts filed with the NBB, the revenue of Depouhon SPRLU amounts to 99,276 €.

What is the VAT number of Depouhon SPRLU?

In Belgium, the VAT number is the company number prefixed with BE: BE0554918687 for Depouhon SPRLU, if the company is VAT-registered. Its company number (CBE) is 0554.918.687.

Where is the registered office of Depouhon SPRLU?

According to the CBE register, the registered office of Depouhon SPRLU is in 1450 Chastre.

What is the equity of Depouhon SPRLU?

At the close of the 2025 financial year, the equity of Depouhon SPRLU amounts to 34,764 €, a solvency of 9.3% of total assets.

Who manages Depouhon SPRLU?

The register lists 1 active mandates at Depouhon SPRLU. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Depouhon SPRLU

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 03 Aug 2026

No credit card, no commitment.

What each plan unlocks →